Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary objective is to evaluate the response rates and clinical benefits of letrozole + goserelin in premenopausal patients versus letrozole alone in postmenopausal patients with metastatic breast cancer as first line hormonal therapy
Critère d'inclusion
- Metastatic breast cancer